Staff Scientist - Precision Oncology of Gastrointestinal Cancers jobs in United States
cer-icon
Apply on Employer Site
company-logo

City of Hope · 3 weeks ago

Staff Scientist - Precision Oncology of Gastrointestinal Cancers

City of Hope is at the forefront of groundbreaking research in the fight against cancer and other life-threatening illnesses. They are seeking a Staff Scientist in Precision Oncology of Gastrointestinal Cancers to contribute to innovative approaches in predicting, preventing, and curing diseases through cutting-edge research.

AssociationEducationHealth Care
check
Comp. & Benefits

Responsibilities

Developing liquid biopsy biomarkers for cancer diagnosis, prognosis, and therapy response prediction
Investigating the epigenetic basis of GI cancers, such as aberrant DNA methylation, histone modifications, and non-coding RNAs
Exploring the genetics of early-onset and familial/hereditary colorectal cancers
Studying the tumor microenvironment, stem cells, immune regulation, and identifying targeted therapies
Investigating extracellular vesicles/exosomes in cancer pathogenesis and as disease biomarkers

Qualification

OncologyCancer biologyTranslational researchMolecular researchImmunologyLiquid biopsyProject developmentScientific rigorHigh-impact publicationsMentoring

Required

PhD, MD, or MD/PhD, with a strong background and profound knowledge in the field of oncology, cancer biology, immunology, or immunotherapy
Prior molecular, cancer biology, and/or translational research experience and evidence of project development and supervision of post-doctoral fellows and technical staff
Evidence of scientific rigor and excellence as documented by high-impact peer-reviewed publications, as a first/lead author
Evidence for obtaining successful funding from various foundations or other extramural resources
Documented evidence of mentoring post-docs, research associates, and others in a research laboratory environment

Benefits

Comprehensive Benefits

Company

City of Hope

company-logo
City of Hope is a cancer research and treatment non-profit organization specializing in diabetes and other life-threatening illnesses.

Funding

Current Stage
Late Stage
Total Funding
$10.3M
Key Investors
California Institute for Regenerative Medicine
2024-05-20Grant· $5.4M
2022-02-22Grant· $4.9M

Leadership Team

leader-logo
Samuel Lau
Vice President Marketing & Digital Communications
linkedin
leader-logo
Alan H. Bryce
Chief Clinical Officer
linkedin
Company data provided by crunchbase